The authors reply

New England Journal of Medicine

Volumn 373, Issue 10, 2015, Pages 978-

  Hayward, Rodney A ^a   Reaven, Peter D ^b   Emanuele, Nicholas V ^c  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LIPID; METFORMIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DOCTOR PATIENT RELATION; ELDERLY CARE; GLYCEMIC CONTROL; HEART PROTECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MEDICAL DECISION MAKING; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT COUNSELING; PRIORITY JOURNAL; BLOOD; CARDIOVASCULAR DISEASES; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE;

EID: 84940870952     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1508386     Document Type: Letter

References (3)

1. Gerstein HC, Miller ME, Ismail-Beigi F, et al. Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. Lancet 2014;384:1936-41.
2. Vijan S, Sussman JB, Yudkin JS, Hayward RA. Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med 2014;174:1227-34.
3. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39.